Liangxue Lai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Liangxue Lai has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Hongsheng Ouyang
Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun 130062, China
1 shared publicationJichao Deng
Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun 130062, China
1 shared publicationMao Chen
Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun 130062, China
1 shared publicationYong Wang
Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun 130062, China
1 shared publicationYuanyuan Xu
Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun 130062, China
1 shared publicationYuning Song
Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun 130062, China
1 shared publication
Latest Publications
- Open Access
- 1 April 2019
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 8 (8) , 2833-2840
Corrigendum
Paired-homeodomain transcription factor 4 (PAX4) gene encodes a transcription factor which plays an important role in the generation, differentiation, development, and survival of insulin-producing β-cells during mammalian pancreas development. PAX4 is a key diabetes mellitus (DM) susceptibility gene, which is associated with many different types of DM, including T1DM, T2DM, maturity onset diabetes of the young 9 (MODY9) and ketosis prone diabetes. In this study, a novel PAX4 gene knockout (KO) model was generated through co-injection of clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (Cas9) mRNA/sgRNA into rabbit zygotes. Typical phenotypes of growth retardation, persistent hyperglycemia, decreased number of insulin-producing β cells and increased number of glucagon-producing α cells were observed in the homozygous PAX4 KO rabbits. Furthermore, DM associated phenotypes including diabetic nephropathy, hepatopathy, myopathy and cardiomyopathy were also observed in the homozygous PAX4 KO rabbits but not in the wild type (WT) controls and the heterozygous PAX4 KO rabbits. In summary, this is the first PAX4 gene KO rabbit model generated by CRISPR/Cas9 system. This novel rabbit model may provide a new platform for function study of PAX4 gene in rabbit and gene therapy of human DM in clinical trails.
- 1 April 2019
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 8 (8) , 2833-2840
Open AccessCorrigendum
Paired-homeodomain transcription factor 4 (PAX4) gene encodes a transcription factor which plays an important role in the generation, differentiation, development, and survival of insulin-producing β-cells during mammalian pancreas development. PAX4 is a key diabetes mellitus (DM) susceptibility gene, which is associated with many different types of DM, including T1DM, T2DM, maturity onset diabetes of the young 9 (MODY9) and ketosis prone diabetes. In this study, a novel PAX4 gene knockout (KO) model was generated through co-injection of clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (Cas9) mRNA/sgRNA into rabbit zygotes. Typical phenotypes of growth retardation, persistent hyperglycemia, decreased number of insulin-producing β cells and increased number of glucagon-producing α cells were observed in the homozygous PAX4 KO rabbits. Furthermore, DM associated phenotypes including diabetic nephropathy, hepatopathy, myopathy and cardiomyopathy were also observed in the homozygous PAX4 KO rabbits but not in the wild type (WT) controls and the heterozygous PAX4 KO rabbits. In summary, this is the first PAX4 gene KO rabbit model generated by CRISPR/Cas9 system. This novel rabbit model may provide a new platform for function study of PAX4 gene in rabbit and gene therapy of human DM in clinical trails.